Essure is a permanent, non-surgical transcervical sterilization procedure developed by Conceptus Inc, a subsidiary of Bayer AG. It was approved for use in the United States on November 4, 2002. 

Small, flexible inserts are placed into the fallopian tubes. The insert contains inner polyethylene terephthalate fibers to induce inflammation causing fibrotic reaction and is held in place by flexible stainless steel inner coil and a dynamic outer nickel titanium alloy coil.

Since 2013, the product has been the subject of controversy with women complaining of severe side effects leading to surgical extraction, and campaigner Erin Brockovich hosting a website where women can share their stories after having the procedure. 

Call in and share your story with us. (646) 668-2716